AnaptysBio, Inc. (ANAB) vs GH Research PLC (GHRS)
A side-by-side comparison of AnaptysBio, Inc. and GH Research PLC across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ANAB
AnaptysBio, Inc.
$47.84HealthcareDelayed quote: Oct 6, 2026, 1:05 PM EDT
GHRS
GH Research PLC
$21.53HealthcareDelayed quote: Oct 6, 2026, 1:05 PM EDT
Total return — ANAB vs GHRS
growth of $100 · dividends reinvested · last 5yANAB +194.8% (+24.1%/yr)GHRS +15.2% (+2.9%/yr)ANAB compounded faster over this window
ANAB GHRS
ANAB vs GHRS: by the numbers
- •GHRS is the larger company ($1.48B vs $1.42B market cap).
- •ANAB is profitable (82.37% net margin) while GHRS runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | ANAB | GHRS |
|---|---|---|
| P/E ratio | 8.91 | N/A |
| P/S ratio | 5.96 | N/A |
| P/B ratio | 133.82 | 4.11 |
| EV / EBITDA | 11.43 | N/A |
| FCF yield | 1.27% | N/A |
Profitability
| Metric | ANAB | GHRS |
|---|---|---|
| Gross margin | 98.97% | 0.00% |
| Operating margin | 20.42% | 0.00% |
| Net margin | 82.37% | 0.00% |
| ROE | 1849.06% | -17.32% |
| ROIC | 47.55% | -19.87% |
Growth (annualized)
| Metric | ANAB | GHRS |
|---|---|---|
| Revenue CAGR (5Y) | 18.60% | N/A |
| FCF CAGR (5Y) | 27.41% | N/A |
| Total return CAGR (5Y) | 21.54% | 0.52% |
Frequently asked
- Is ANAB or GHRS more profitable?
- ANAB runs the higher net margin — ANAB at 82.37% versus GHRS at 0.00%.
- How have ANAB and GHRS total returns compared?
- Over the past 5 years, ANAB delivered 21.54% and GHRS delivered 0.52% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AnaptysBio P/E ratioAnaptysBio ROEGH Research ROEAnaptysBio operating marginGH Research operating marginAnaptysBio revenue growthGH Research revenue growthAnaptysBio free cash flowGH Research free cash flow
AnaptysBio & GH Research appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.